A new method to modify the C-4 position of 10-deacetylbaccatin III

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 12, 1997, Pages 2093-2095

  Uoto, Kouichi ^a   Takenoshita, Haruhiro ^a   Ishiyama, Takashi ^a   Terasawa, Hirofumi ^a   Soga, Tsunehiko ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

10 deacetylbaccatin III; Alkylation; Anion; C 4 acetyl group; Paclitaxel; Taxoid

Indexed keywords

BACCATIN III; PACLITAXEL; TAXOID;

ARTICLE; BREAST CARCINOMA; CANCER CONTROL; DRUG FORMULATION; DRUG STRUCTURE; DRUG SYNTHESIS; OVARY CARCINOMA;

EID: 0031471129     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.2093     Document Type: Article

References (17)

1. Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T., J. Am. Chem. Soc., 93, 2325-2327 (1971).
2. a) Schiff P. B., Fant J., Horwitz S. B., Nature (London), 277, 665-667 (1979);
3. b) Manfredi J. J., Horwitz S. B., Pharmacol. Ther., 25, 83-125 (1984);
4. c) Ringel I., Horwitz S. B., J. Natl. Cancer Inst., 83, 288-291 (1991).
5. a) Chen S.-H., Kadow J. F., Farina V., J. Org. Chem., 59, 6156-6158 (1994);
6. b) Chen S.-H., Wei J.-M., Long B. H., Fairchild C. A., Carboni J., Mamber S. W., Rose W. C., Johnston K., Casazza A. M., Kadow J. F., Farina V., Vyas D. M., Doyle T. W., Bioorg. Med. Chem. Lett., 5, 2741-2746 (1995);
7. c) Chen S.-H., Fairchild C. A., Long B. H., J. Med. Chem., 38, 2263-2267 (1995).
8. Denis J.-D., Greene A. E., Guenard D., Gueritte-Voegelein F., Mangatal L., Potier P., J. Aw. Chem .Soc., 110, 5917-5919 (1988).
9. a) Nicolaou K. C., Renaud J., Nantermet P. G., Couladouros R. K., Wrasidlo W., J. Am. Chem. Soc., 117, 2409-2420 (1995);
10. b) Appendino G., Jakupovic J., Cravotto G., Enriu R., Varese M., Bombardelli E., Tetrahedron Lett., 36, 3233-3236 (1995);
11. c) Marder R., Dubois J., Guenard D., Gueritte-Voegelein F., Potier P., Tetrahedron, 51, 1985-1994 (1995);
12. d) Marder R., Bricard L., Dubois J., Guenard D., Gueritte-Voegelein F., Tetrahedron Lett., 37, 1777-1780 (1996).
13. Potassium bis(trimethylsilyl)amide (KHMDS) was not tested.
14. For example: a) Kant J., O'Keeffe W. S., Chen S.-H., Farina V., Fairchild C. A., Johnston K., Kadow J. F., Long B. H., Vyas D. M., Tetrahedron Lett., 35, 5543-5546 (1994); b) Ojima I., Slater J. C., Michaud E., Kuduk S. D., Bounaud P.-Y., Vrignaud P., Bissery M. -C., Veith J., Pera P., Bernacki R. J., J. Med. Chem., 39, 3889-3896 (1996).
15. For example: a) Kant J., O'Keeffe W. S., Chen S.-H., Farina V., Fairchild C. A., Johnston K., Kadow J. F., Long B. H., Vyas D. M., Tetrahedron Lett., 35, 5543-5546 (1994); b) Ojima I., Slater J. C., Michaud E., Kuduk S. D., Bounaud P.-Y., Vrignaud P., Bissery M. -C., Veith J., Pera P., Bernacki R. J., J. Med. Chem., 39, 3889-3896 (1996).
16. Terasawa H., Soga T., Uoto K., PCT Int. Appl. WO 9623779-A1 (1996) [Chem. Abstr., 125, 222219s (1996)]. This will be reported in detail in the near future.
17. Terasawa H., Soga T., Uoto K., PCT Int. Appl. WO 9623779-A1 (1996) [Chem. Abstr., 125, 222219s (1996)]. This will be reported in detail in the near future.